Search research articles
Contact Us
Filters
Showing results (41-50 of 168) with videos related to
Page
of 17
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 17, 2026
Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR Pseudomonas aeruginosa infections: a systematic review and meta-analysis
Milo Gatti, Riccardo De Paola, Beatrice Giorgi, et al.
International Journal of Antimicrobial Agents
|
April 6, 2024
In reply to the Letter to the Editor regarding "Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis"
Milo Gatti, Federica Cosentino, Maddalena Giannella, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues
Milo Gatti, Eleonora Turrini, Emanuel Raschi, et al.
Drug Design, Development and Therapy
|
August 11, 2021
Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap
Nicolina Conti, Milo Gatti, Emanuel Raschi, et al.
Therapeutic Drug Monitoring
|
August 8, 2024
Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Ceftolozane and Tazobactam in Human Plasma Microsamples
Matteo Conti, Beatrice Giorgi, Milo Gatti, et al.
British Journal of Clinical Pharmacology
|
November 7, 2022
Clinical efficacy of renal dosing adjustments of ceftazidime-avibactam in patients affected by carbapenem-resistant Gram-negative infections: A systematic review and meta-analysis of observational studies
Milo Gatti, Giacomo Fornaro, Pierluigi Viale, et al.
Microorganisms
|
January 25, 2025
Usefulness of a TDM-Guided Approach for Optimizing Teicoplanin Exposure in the Treatment of Secondary Bloodstream Infections Caused by Glycopeptide-Susceptible <i>Enterococcus faecium</i>
Milo Gatti, Matteo Rinaldi, Maddalena Giannella, et al.
Molecules (Basel, Switzerland)
|
July 13, 2024
Colistin: Lights and Shadows of an Older Antibiotic
Erica Diani, Gabriele Bianco, Milo Gatti, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
September 6, 2023
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach
Milo Gatti, Sara Tedeschi, Eleonora Zamparini, et al.
International Journal of Antimicrobial Agents
|
December 7, 2023
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis
Milo Gatti, Federica Cosentino, Maddalena Giannella, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 168) with videos related to
Sort By:
Page
of 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 17, 2026
Comparison of ceftolozane-tazobactam and ceftazidime-avibactam in the treatment of MDR/DTR Pseudomonas aeruginosa infections: a systematic review and meta-analysis
Milo Gatti, Riccardo De Paola, Beatrice Giorgi, et al.
International Journal of Antimicrobial Agents
|
April 6, 2024
In reply to the Letter to the Editor regarding "Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis"
Milo Gatti, Federica Cosentino, Maddalena Giannella, et al.
Pharmaceuticals (Basel, Switzerland)
|
August 28, 2021
Janus Kinase Inhibitors and Coronavirus Disease (COVID)-19: Rationale, Clinical Evidence and Safety Issues
Milo Gatti, Eleonora Turrini, Emanuel Raschi, et al.
Drug Design, Development and Therapy
|
August 11, 2021
Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap
Nicolina Conti, Milo Gatti, Emanuel Raschi, et al.
Therapeutic Drug Monitoring
|
August 8, 2024
Development and Validation of a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Ceftolozane and Tazobactam in Human Plasma Microsamples
Matteo Conti, Beatrice Giorgi, Milo Gatti, et al.
British Journal of Clinical Pharmacology
|
November 7, 2022
Clinical efficacy of renal dosing adjustments of ceftazidime-avibactam in patients affected by carbapenem-resistant Gram-negative infections: A systematic review and meta-analysis of observational studies
Milo Gatti, Giacomo Fornaro, Pierluigi Viale, et al.
Microorganisms
|
January 25, 2025
Usefulness of a TDM-Guided Approach for Optimizing Teicoplanin Exposure in the Treatment of Secondary Bloodstream Infections Caused by Glycopeptide-Susceptible <i>Enterococcus faecium</i>
Milo Gatti, Matteo Rinaldi, Maddalena Giannella, et al.
Molecules (Basel, Switzerland)
|
July 13, 2024
Colistin: Lights and Shadows of an Older Antibiotic
Erica Diani, Gabriele Bianco, Milo Gatti, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
September 6, 2023
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach
Milo Gatti, Sara Tedeschi, Eleonora Zamparini, et al.
International Journal of Antimicrobial Agents
|
December 7, 2023
Clinical efficacy of cefiderocol-based regimens in patients with carbapenem-resistant Acinetobacter baumannii infections: A systematic review with meta-analysis
Milo Gatti, Federica Cosentino, Maddalena Giannella, et al.
Page
of 17